Michael Petusky

Stock Analyst at Barrington Research

(2.35)
# 2,530
Out of 5,136 analysts
218
Total ratings
44.67%
Success rate
-1.11%
Average return

Stocks Rated by Michael Petusky

Haemonetics
Jan 12, 2026
Maintains: Outperform
Price Target: $90$93
Current: $75.31
Upside: +23.49%
Anika Therapeutics
Jan 9, 2026
Maintains: Outperform
Price Target: $16
Current: $9.39
Upside: +70.39%
VerifyMe
Jan 6, 2026
Maintains: Outperform
Price Target: $1$1.5
Current: $1.37
Upside: +9.89%
U.S. Physical Therapy
Jan 5, 2026
Maintains: Outperform
Price Target: $103
Current: $88.04
Upside: +16.99%
DENTSPLY SIRONA
Jan 5, 2026
Maintains: Outperform
Price Target: $14
Current: $12.52
Upside: +11.82%
Merit Medical Systems
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $81.08
Upside: +30.74%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $78$79
Current: $77.66
Upside: +1.73%
Orthofix Medical
Nov 5, 2025
Maintains: Outperform
Price Target: $17$18
Current: $14.35
Upside: +25.44%
Option Care Health
Oct 31, 2025
Maintains: Outperform
Price Target: $38
Current: $36.12
Upside: +5.20%
OPKO Health
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.28
Upside: +75.78%
Maintains: Outperform
Price Target: $95
Current: $87.29
Upside: +8.83%
Downgrades: Market Perform
Price Target: n/a
Current: $8.01
Upside: -